Argenx is seeking a Senior Director of Patient Marketing Dual Asset Strategy to lead the commercial strategy for their products Vyvgart and Empa within the CIDP and MMN therapeutic areas. This role requires a strong background in biopharma marketing, particularly in specialty and rare diseases, to maximize growth and execute dual-asset positioning.
Base: $236,000.00 - $324,500.00 USD annually; Bonus/Equity: Eligible for short-term and long-term incentive programs; Benefits: Comprehensive package including retirement savings and health benefits
Must-have
Nice-to-have
Not specified